Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Northcoast Research upped their Q2 2018 EPS estimates for Henry Schein in a research report issued on Tuesday. Northcoast Research analyst E. Snyder now expects that the company will post earnings per share of $1.00 for the quarter, up from their previous forecast of $0.96. Northcoast Research also issued estimates for Henry Schein’s Q3 2018 earnings at $1.04 EPS, Q4 2018 earnings at $1.15 EPS and FY2018 earnings at $4.11 EPS.
A number of other analysts have also issued reports on HSIC. Royal Bank of Canada reduced their price target on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a research report on Tuesday, November 7th. Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. Stifel Nicolaus cut their price objective on shares of Henry Schein from $89.00 to $77.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Leerink Swann reiterated a “market perform” rating and set a $77.00 price target (down previously from $87.50) on shares of Henry Schein in a report on Tuesday, November 7th. Finally, Jefferies Group lowered their price target on Henry Schein from $89.00 to $74.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $83.57.
Henry Schein (NASDAQ:HSIC) traded down $0.71 during midday trading on Friday, hitting $67.97. 1,891,700 shares of the stock were exchanged, compared to its average volume of 2,092,397. The company has a quick ratio of 0.86, a current ratio of 1.45 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $10,555.72, a price-to-earnings ratio of 19.10, a price-to-earnings-growth ratio of 1.70 and a beta of 1.00. Henry Schein has a 1-year low of $63.01 and a 1-year high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.97 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.97. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. The company had revenue of $3.32 billion during the quarter, compared to analyst estimates of $3.30 billion. During the same quarter last year, the firm posted $0.94 EPS. The business’s revenue for the quarter was up 6.3% on a year-over-year basis.
In other news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $70.76, for a total value of $410,124.96. Following the sale, the director now owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 1.19% of the company’s stock.
Institutional investors have recently made changes to their positions in the company. FTB Advisors Inc. grew its stake in shares of Henry Schein by 100.0% in the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock worth $120,000 after acquiring an additional 742 shares during the last quarter. Trust Co. of Vermont grew its stake in shares of Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock worth $140,000 after acquiring an additional 616 shares during the last quarter. Lee Financial Co grew its stake in shares of Henry Schein by 100.0% in the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock worth $144,000 after acquiring an additional 878 shares during the last quarter. JNBA Financial Advisors grew its stake in shares of Henry Schein by 100.0% in the third quarter. JNBA Financial Advisors now owns 2,000 shares of the company’s stock worth $164,000 after acquiring an additional 1,000 shares during the last quarter. Finally, Westside Investment Management Inc. grew its stake in shares of Henry Schein by 100.0% in the third quarter. Westside Investment Management Inc. now owns 2,000 shares of the company’s stock worth $160,000 after acquiring an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 88.58% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Q2 2018 EPS Estimates for Henry Schein, Inc. (HSIC) Raised by Analyst” was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.thelincolnianonline.com/2018/02/23/q2-2018-eps-estimates-for-henry-schein-inc-hsic-raised-by-analyst.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.